SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HuMAB companies
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (546)6/23/2003 2:48:27 PM
From: keokalani'nui  Read Replies (1) of 1022
 
Thanks for the post.

>>My gut says that the MEDX antibody is better because it binds a conformational epitope while J591 binds a linear epitope (a long science discussion)<<

Gut? His "gut" can be found at slide #25, medx's presentation at the GS conf.

BTW, there have actually been some objective responses, even at least one CR, using gp100 in metastatic melanoma using novel adjuvants like il-2 and/or gc-sf (I'm sure I've got the abbr. wrong on that one).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News